site stats

Sangamo therapeutics aktie

WebbOperating Status Active. Last Funding Type Post-IPO Equity. Legal Name Sangamo Therapeutics, Inc. Stock Symbol NASDAQ:SGMO. Company Type For Profit. Contact Email [email protected]. Phone Number 5102368951. Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic … WebbDescription. Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, …

Sangamo poised for CAR-Treg race Nature Biotechnology

Webb13 apr. 2024 · 5 equities research analysts have issued 12-month price targets for Sangamo Therapeutics' shares. Their SGMO share price forecasts range from $5.00 to $16.00. On average, they anticipate the company's stock price to reach $12.80 in the next year. This suggests a possible upside of 759.1% from the stock's current price. do gildan shirts bleach https://nhacviet-ucchau.com

Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present

WebbSangamo Therapeutics, Inc. 4 years 2 months Vice President, Neuroscience Sangamo Therapeutics, Inc. Apr 2024 - Present 3 years 1 … Webb17 mars 2024 · Sangamo Therapeutics Inc.’s market cap currently stands at around $365.21 million, with investors looking forward to this quarter’s earnings report slated for May 03, 2024 – May 08, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.36, which has seen fiscal year 2024 EPS growth forecast to increase to -$1.3 and … WebbAnswerThePublic listens into autocomplete data from search engines like Google then quickly cranks out every useful phrase and question people are asking around sangamo therapeutics on 02 Feb.. It’s a goldmine of consumer insight you can use to create fresh, ultra-useful content, products and services. do g.i loans permit easements on the property

Sangamo Therapeutics Inc Teknisk analys av aktie (SGMO)

Category:SGMO: Sangamo Therapeutics Inc - Stock Price, Quote and News

Tags:Sangamo therapeutics aktie

Sangamo therapeutics aktie

Sangamo Therapeutics, Inc. Common Stock (SGMO)

WebbOverview Sangamo Therapeutics, Inc. WebbSangamo Therapeutics-Aktie Inspiring Watchlist der Woche: das BX Musterportfolio mit François Bloch +22% in den letzten 12 Monaten Sangamo Therapeutics Aktie VALOR …

Sangamo therapeutics aktie

Did you know?

Webb2 maj 2024 · Sangamo Therapeutics to Present Data at 2024 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) Sangamo Therapeutics, Inc. (Nasdaq: … WebbSangamo Therapeutics-Aktie. Inspiring Watchlist der Woche: das BX Musterportfolio mit François Bloch +22% in den letzten 12 Monaten. Sangamo Therapeutics Aktie VALOR 1066659 / ISIN US8006771062.

Webb3 jan. 2024 · Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and Pfizer Inc. (NYSE: PFE) today announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors (ZFP-TFs) to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 … WebbSGMO Complete Sangamo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Webb6 apr. 2024 · Sangamo Therapeutics - SGMO News Today $1.63 -0.04 (-2.40%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $1.61 $1.70 50-Day Range $1.63 $3.67 52-Week Range $1.58 $6.42 Volume 1.67 million shs Average Volume 2.28 million shs Market Capitalization $274.62 million P/E Ratio N/A Dividend Yield N/A Price Target … Webb16 rader · 12 apr. 2024 · SANGAMO THERAPEUTICS Aktie jetzt für 0€ handeln: 21.03. Double blow for Sangamo as Novartis, Biogen exit deals: 52: pharmaphorum: 20.03.

WebbSangamo Therapeutics information: analys, aktiekurs, aktiekurshistorik, kursdiagram, utdelningar, ekonomi, nyckeltal, antal aktier, kapitalisering, senaste nyheter

Webb20 juli 2024 · RICHMOND, Calif. and VALBONNE, France, Oct. 1, 2024 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and TxCell S.A. (ENXTPA: TXCL) today jointly announced the completion by Sangamo of the acquisition of ordinary shares of TxCell, at a price of €2.58 per share in cash, representing approximately 53% of the share capital and … fahrrad unterhose decathlonWebbSangamo Therapeutics (SGMO) aktie Nordnet Sangamo Therapeutics (SGMO) Senast 2,26 Idag % −1,74% Idag +/- −0,04 Köp 2,27 Sälj 2,28 Högst 2,33 Lägst 2,13 22:00:00 · Valuta i USD Nasdaq Köp Sälj Översikt Om bolaget Upplösn Ingen data hittades, välj annat tidsintervall. Shareville Inga inlägg har publicerats under de senaste 6 månaderna. dog illustration freeWebbSGMO Stock 12 Months Forecast. $10.89. (518.75% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $10.89 with a high forecast of $16.00 and a low forecast of $4.20. The average price target represents a 518.75% change from the last price of $1.76. fahrrad usedomWebb21 feb. 2024 · Sangamo Therapeutics Inc Aktie Profil. Die Sangamo Therapeutics Inc Aktie wird unter der ISIN US8006771062 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Berlin, ... fahrrad uth altdorfWebb14 juli 2024 · Sangamo Therapeutics, Inc. 2 years 11 months Sr. Director, Vector Process Development (DS) and Formulation & Fill/Finish (DP) ... fahrradurlaub in hollandWebbSangamo Therapeutics (SGMO) aktie Nordnet Sangamo Therapeutics (SGMO) Senest 2,26 I dag % -1,74% I dag +/- -0,04 Køb 2,27 Sælg 2,28 Højest 2,33 Lavest 2,13 22.00.00 · … dog illness from drinking dirty waterWebbSangamo Therapeutics är ett bioteknikbolag. Bolaget fokuserar på forskning och utveckling av genomiska terapier, samt utvecklar läkemedel för patienter med genetiska … dog images white background